BUPE for Recovery Act

This bill temporarily removes buprenorphine products (used to treat opioid use disorder) from the Suspicious Orders Report System (SORS) during the opioid public health emergency. It exempts these medications from SORS reporting requirements for 270 days after the emergency ends, aiming to test if this change increases patient access to treatment. Pharmacies and patients with opioid use disorder are directly affected, as the exemption addresses concerns that SORS reporting burdens limit buprenorphine availability. The bill requires a federal report 90 days after the emergency ends, evaluating whether the exemption improved access and recommending whether to keep the exemption permanent. The measure is a temporary data-gathering step, not a permanent policy change.